These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1489895)

  • 1. Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A.
    Grøn B; Filion-Myklebust C; Bennick A; Nieuwenhuizen W; Matsueda GR; Brosstad F
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):731-6. PubMed ID: 1489895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
    Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
    Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A.
    Grøn B; Bennick A; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1990 Jan; 57(2):259-70. PubMed ID: 2315888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.
    Francis CW; Marder VJ
    J Clin Invest; 1987 Nov; 80(5):1459-65. PubMed ID: 3680507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
    Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
    Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
    Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
    Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of plasma factor XIII binding to fibrin in vitro.
    Greenberg CS; Dobson JV; Miraglia CC
    Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of soluble fibrin oligomers in purified systems and in plasma.
    Alkjaersig N; Fletcher AP
    Biochem J; 1983 Jul; 213(1):75-83. PubMed ID: 6615433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated study of fibrinogen during blood coagulation.
    Brummel KE; Butenas S; Mann KG
    J Biol Chem; 1999 Aug; 274(32):22862-70. PubMed ID: 10428872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Clin Invest; 1971 Jul; 50(7):1506-13. PubMed ID: 5090065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.